what are the fda approved glp 1 drugs which for obesity What's New in Obesity Treatment? GLP-1 Genetics: How Genes Affect
Description
The Study of Tirzepatide (LY3298176) in Participants With Obesity (SURMOUNT-1) trial found that tirzepatide at 15 mg per week taken over 72 weeks reduced body weight by 20.9% in those with obesity but without diabetes [9]

[DOI] [PMC free article] [PubMed] [Google Scholar] 96.Kenny P.R., Brady D.E., Torres D.M., Ragozzino L., Chalasani N., Harrison S.A

Source: 1 Cleveland Clinic GLP-1 Agonists

Maybe the first question we should be asking is whats in a nameor more aptly, what isnt

Mounjaro, known as tirzepatide, is a prescription medicine
